Private and public payers, as well as patients, want access and have been calling for lower list prices, Jamey Millar, executive vice president for US operations of Novo Nordisk, said in the announcement
A dose reduction of one tier, held for six to eight weeks before re-escalation, is a legitimate clinical approach
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management
Over the past few decades several hormones from various body systems involved in food intake have been targeted as potential treatments for obesity and diabetes, but GLP-1 seems to be the one thats risen to the top, at least for pharmacotherapy, says Scott Kanoski, a behavioral neuroscientist and professor at the University of Southern California
Stuber and Wise, 2016) but repeated exposure to such foods can profoundly reshape function of such brain circuits that further promote the intake of these calorie dense foods at the expense of less palatable, lower calorie foods that offer an overall superior nutritional profile (Wang et al., 2001
